148 related articles for article (PubMed ID: 28228322)
1. Anti-tumour research of recombinant BCG using BZLF1 and hGM-CSF fusion genes.
Xue QJ; Li YQ; Yang CQ; Chen T; Li XZ; Cheng B; Wang CM
Vaccine; 2017 Mar; 35(12):1599-1607. PubMed ID: 28228322
[TBL] [Abstract][Full Text] [Related]
2. Construction of a recombinant-BCG containing the LMP2A and BZLF1 genes and its significance in the Epstein-Barr virus positive gastric carcinoma.
Xue QJ; Dai J; Li XZ; Zhu W; Si CP; Chen T
J Med Virol; 2014 Oct; 86(10):1780-7. PubMed ID: 24699993
[TBL] [Abstract][Full Text] [Related]
3. EB virus-positive tumors are inhibited by rBCG expressing hGM-CSF and LMP2A.
Yan Y; Xue QJ; Liu A; Wang H; Zhang H; Wang S; Zhao L; Li Y; Li X; Yang Y; Chen T; Li S
Hum Vaccin Immunother; 2020 Mar; 16(3):654-663. PubMed ID: 31567046
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory effect of rBCG on EB virus-positive tumours using an EB virus fusion gene.
Xue QJ; Yu HX; Liu A; Wang H; Li YQ; Chen T; Wang QL
Appl Microbiol Biotechnol; 2022 Jan; 106(1):185-195. PubMed ID: 34854938
[TBL] [Abstract][Full Text] [Related]
5. Effective anti-tumor responses induced by recombinant bacillus Calmette-Guérin vaccines based on different tandem repeats of MUC1 and GM-CSF.
Yuan S; Shi C; Han W; Ling R; Li N; Wang T
Eur J Cancer Prev; 2009 Sep; 18(5):416-23. PubMed ID: 19550341
[TBL] [Abstract][Full Text] [Related]
6. Construction of rBCG carrying the IL-2-BZLF1 fusion gene and its immunological function.
Yu M; Mi T; Lu J; Cui L; Xue Q; Xiong H; Li Y
Appl Microbiol Biotechnol; 2024 Dec; 108(1):19. PubMed ID: 38170315
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70.
Dai FY; Wang JF; Gong XL; Bao L
Hum Vaccin Immunother; 2017 Jun; 13(6):1-8. PubMed ID: 28301284
[TBL] [Abstract][Full Text] [Related]
8. Recombinant BCG coexpressing Ag85B, ESAT-6 and Rv3620c elicits specific Th1 immune responses in C57BL/6 mice.
Yang E; Lu Y; Xu Y; Liang Q; Wang C; Wang H; Shen H
Microb Pathog; 2014; 69-70():53-9. PubMed ID: 24726737
[TBL] [Abstract][Full Text] [Related]
9. Recombinant BCG expressing a PspA-PdT fusion protein protects mice against pneumococcal lethal challenge in a prime-boost strategy.
Goulart C; Rodriguez D; Kanno AI; Lu YJ; Malley R; Leite LC
Vaccine; 2017 Mar; 35(13):1683-1691. PubMed ID: 28242071
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of human interferon-alpha 2b secreted by recombinant bacillus Calmette-Guérin vaccine on bladder cancer cells.
Ding GQ; Yu YL; Shen ZJ; Zhou XL; Chen SW; Liao GD; Zhang Y
J Zhejiang Univ Sci B; 2012 May; 13(5):335-41. PubMed ID: 22556170
[TBL] [Abstract][Full Text] [Related]
12. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
[TBL] [Abstract][Full Text] [Related]
13. The immunotherapeutic effects of recombinant Bacillus Calmette-Guérin resistant to antimicrobial peptides on bladder cancer cells.
Cho MJ; Kim MJ; Kim K; Choi YW; Lee SJ; Whang YM; Chang IH
Biochem Biophys Res Commun; 2019 Jan; 509(1):167-174. PubMed ID: 30579607
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
15. Oral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T-lymphocyte responses in mice.
Lagranderie M; Balazuc AM; Gicquel B; Gheorghiu M
J Virol; 1997 Mar; 71(3):2303-9. PubMed ID: 9032366
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6.
Deng YH; He HY; Zhang BS
J Microbiol Immunol Infect; 2014 Feb; 47(1):48-56. PubMed ID: 23357605
[TBL] [Abstract][Full Text] [Related]
17. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
18. [Construction, expression and identification of recombinant bacillus Calmette-Guérin vaccine secreting human interferon alpha-2a].
Liu HT; Sun XW; Zhang YN; Zhuo J; Fan J; Wang F; Xia SJ
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(34):2417-20. PubMed ID: 17156655
[TBL] [Abstract][Full Text] [Related]
19. Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy.
Zheng YQ; Naguib YW; Dong Y; Shi YC; Bou S; Cui Z
Expert Rev Vaccines; 2015; 14(9):1255-75. PubMed ID: 26268434
[TBL] [Abstract][Full Text] [Related]
20. [Construction of recombinant bacillus Calmette-Guérin vaccine secreting human interferon-alpha 2b].
Ding GQ; Shen ZJ; Chen SW; Zhou XL; Liao GD
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(13):1022-6. PubMed ID: 19035208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
